Passive smoking

Terminology

Fritz Lickint created the term "passive smoking" ("Passivrauchen") in a publication in the German language during the 1930s. Terms used include "environmental tobacco smoke" to refer to the airborne matter, while "involuntary smoking" and "passive smoking" refer to exposure to secondhand smoke. The term "environmental tobacco smoke" can be traced back to a 1974 industry-sponsored meeting held in Bermuda, while the term "passive smoking" was first used in the title of a scientific paper in 1970.

The term "sidestream smoke" is sometimes used to refer to smoke that goes into the air directly from a burning cigarette, cigar, or pipe, while "mainstream smoke" refers to smoke that a smoker exhales.

Health effects

Secondhand smoke causes many of the same diseases as direct smoking, including cardiovascular diseases, lung cancer, and respiratory diseases. These include:

• Cancer:
  • General: overall increased risk; reviewing the evidence accumulated on a worldwide basis, the International Agency for Research on Cancer concluded in 2004 that "Involuntary smoking (exposure to secondhand or 'environmental' tobacco smoke) is carcinogenic to humans."
  • Lung cancer: Passive smoking is a risk factor for lung cancer. In the United States, secondhand smoke is estimated to cause more than 7,000 deaths from lung cancer a year among non-smokers. A quarter of all cases occur in people who have never smoked.
  • Breast cancer: The California Environmental Protection Agency concluded in 2005 that passive smoking increases the risk of breast cancer in younger, primarily premenopausal females by 70% and the US Surgeon General has concluded that the evidence is "suggestive", but still insufficient to assert such a causal relationship. In contrast, the International Agency for Research on Cancer concluded in 2004 that there was "no support for a causal relation between involuntary exposure to tobacco smoke and breast cancer in never-smokers."
  • Cervical cancer: A 2015 overview of systematic reviews found that exposure to secondhand smoke increased the risk of cervical cancer.
  • Bladder cancer: A 2016 systematic review and meta-analysis found that secondhand smoke exposure was associated with a significant increase in the risk of bladder cancer.
• Circulatory system: risk of heart disease and reduced heart rate variability.
  • Epidemiological studies have shown that both active and passive cigarette smoking increase the risk of atherosclerosis.
  • Passive smoking is strongly associated with an increased risk of stroke, and this increased risk is disproportionately high at low levels of exposure.
• Lung problems:
  • Risk of asthma
  • Risk of chronic obstructive pulmonary disease (COPD)
  • According to a 2015 review, passive smoking may increase the risk of tuberculosis infection and accelerate the progression of the disease, but the evidence remains weak.
  • The majority of studies on the association between secondhand smoke exposure and sinusitis have found a significant association between the two.
• Cognitive impairment and dementia: Exposure to secondhand smoke may increase the risk of cognitive impairment and dementia in adults 50 and over. Children exposed to secondhand smoke show reduced vocabulary and reasoning skills when compared with non-exposed children as well as more general cognitive and intellectual deficits.
• Mental health: Exposure to secondhand smoke is associated with an increased risk of depressive symptoms.
• During pregnancy:
  • Miscarriage: a 2014 meta-analysis found that maternal secondhand smoke exposure increased the risk of miscarriage by 11%.
  • Low birth weight, part B, ch. 3.
  • Premature birth, part B, ch. 3 (Evidence of the causal link is described only as "suggestive" by the US Surgeon General in his 2006 report.) Laws limiting smoking decrease premature births.
  • Stillbirth and congenital malformations in children
  • Recent studies comparing females exposed to secondhand smoke and non-exposed females, demonstrate that females exposed while pregnant have higher risks of delivering a child with congenital abnormalities, longer lengths, smaller head circumferences, and neural tube defects.
• General:
  • Worsening of asthma, allergies, and other conditions. A 2014 systematic review and meta-analysis found that passive smoking was associated with a slightly increased risk of allergic diseases among children and adolescents; the evidence for an association was weaker for adults.
  • Type 2 diabetes. It remains unclear whether the association between passive smoking and diabetes is causal.
• Risk of carrying Neisseria meningitidis or Streptococcus pneumoniae.
• A possible increased risk of periodontitis.
• Overall increased risk of death in both adults, where it was estimated to kill 53,000 nonsmokers per year in the U.S in 1991, and in children. The World Health Organization states that passive smoking causes about 600,000 deaths a year, and about 1% of the global burden of disease. As of 2017, passive smoking causes about 900,000 deaths a year, which is about 1/8 of all deaths caused by smoking.
• Skin conditions: A 2016 systematic review and meta-analysis found that passive smoking was associated with a higher rate of atopic dermatitis.

Risk to children

• Sudden infant death syndrome (SIDS). In his 2006 report, the US Surgeon General concludes: "The evidence is sufficient to infer a causal relationship between exposure to secondhand smoke and sudden infant death syndrome." Secondhand smoking has been estimated to be associated with 430 SIDS deaths in the United States annually.
• Asthma. Secondhand smoke exposure is also associated with an almost doubled risk of hospitalization for asthma exacerbation among children with asthma.
• Lung infections, also including more severe illness with bronchiolitis and worse outcome, as well as increased risk of developing tuberculosis if exposed to a carrier. In the United States, it is estimated that secondhand smoke has been associated with between 150,000 and 300,000 lower respiratory tract infections in infants and children under 18 months of age, resulting in between 7,500 and 15,000 hospitalizations each year.
• Impaired respiratory function and slowed lung growth
• Allergies
• Maternal passive smoking increases the risk of non-syndromic orofacial clefts by 50% among their children.
• Learning difficulties, developmental delays, executive function problems, and neurobehavioral effects. Animal models suggest a role for nicotine and carbon monoxide in neurocognitive problems.
• Increased risk of middle ear infections.
• Invasive meningococcal disease.
• Anesthesia complications and some negative surgical outcomes.
• Sleep disordered breathing: Most studies have found a significant association between passive smoking and sleep disordered breathing in children, but further studies are needed to determine whether this association is causal.
• Adverse effects on the cardiovascular system of children.

Evidence

Epidemiological studies show that non-smokers exposed to secondhand smoke are at risk for many of the health problems associated with direct smoking.

In 1992, a review estimated that secondhand smoke exposure was responsible for 35,000 to 40,000 deaths per year in the United States in the early 1980s. The absolute risk increase of heart disease due to ETS was 2.2%, while the attributable risk percent was 23%. A 1997 meta-analysis found that secondhand smoke exposure increased the risk of heart disease by a quarter, and two 1999 meta-analyses reached similar conclusions.

Evidence shows that inhaled sidestream smoke, the main component of secondhand smoke, is about four times more toxic than mainstream smoke. This fact has been known to the tobacco industry since the 1980s, though it kept its findings secret. Some scientists believe that the risk of passive smoking, in particular the risk of developing coronary heart diseases, may have been substantially underestimated.

In 1997, a meta-analysis on the relationship between secondhand smoke exposure and lung cancer concluded that such exposure caused lung cancer. The increase in risk was estimated to be 24% among non-smokers who lived with a smoker. In 2000, Copas and Shi reported that there was clear evidence of publication bias in the studies included in this meta-analysis. They further concluded that after correcting for publication bias, and assuming that 40% of all studies are unpublished, this increased risk decreased from 24% to 15%. This conclusion has been challenged on the basis that the assumption that 40% of all studies are unpublished was "extreme". A 2000 meta-analysis found a relative risk of 1.48 for lung cancer among men exposed to secondhand smoke, and a relative risk of 1.16 among those exposed to it at work. Another meta-analysis confirmed the finding of an increased risk of lung cancer among women with spousal exposure to secondhand smoke the following year. It found a relative risk of lung cancer of 1.29 for women exposed to secondhand smoke from their spouses. A 2014 meta-analysis noted that "the association between exposure to secondhand smoke and lung cancer risk is well established."

A minority of epidemiologists have found it hard to understand how secondhand smoke, which is more diluted than actively inhaled smoke, could have an effect that is such a large fraction of the added risk of coronary heart disease among active smokers. One proposed explanation is that secondhand smoke is not simply a diluted version of "mainstream" smoke, but has a different composition with more toxic substances per gram of total particulate matter. Passive smoking appears to be capable of precipitating the acute manifestations of cardio-vascular diseases (atherothrombosis) and may also have a negative impact on the outcome of patients who have acute coronary syndromes.

In 2004, the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) reviewed all significant published evidence related to tobacco smoking and cancer. It concluded:

Subsequent meta-analyses have confirmed these findings.

The National Asthma Council of Australia cites studies showing that secondhand smoke is probably the most important indoor pollutant, especially around young children:

• Smoking by either parent, particularly by the mother, increases the risk of asthma in children.
• The outlook for early childhood asthma is less favourable in smoking households.
• Children with asthma who are exposed to smoking in the home generally have more severe disease.
• Many adults with asthma identify ETS as a trigger for their symptoms.
• Doctor-diagnosed asthma is more common among non-smoking adults exposed to ETS than those not exposed. Among people with asthma, higher ETS exposure is associated with a greater risk of severe attacks.

In France, exposure to secondhand smoke has been estimated to cause between 3,000 and 5,000 premature deaths per year, with the larger figure cited by Prime Minister Dominique de Villepin during his announcement of a nationwide smoke-free law: "That makes more than 13 deaths a day. It is an unacceptable reality in our country in terms of public health."

There is good observational evidence that smoke-free legislation reduces the number of hospital admissions for heart disease.

Exposure and risk levels

The International Agency for Research on Cancer of the World Health Organization concluded in 2004 that there was sufficient evidence that secondhand smoke caused cancer in humans. Workers particularly at risk of exposure include those in installation repair and maintenance, construction and extraction, and transportation.

Much research has come from studies of nonsmokers who are married to a smoker. The US Surgeon General, in his 2006 report, estimated that living or working in a place where smoking is permitted increases the non-smokers' risk of developing heart disease by 25–30% and lung cancer by 20–30%.

Similarly, children who are exposed to environmental tobacco smoke are shown to experience a range of adverse effects and a higher risk of becoming smokers later in life. The WHO has identified reduction of exposure to environmental tobacco smoke as key element for actions to encourage healthy child development.

The US Centers for Disease Control and Prevention monitors the extent of and trends in exposure to environmental tobacco smoke by measuring serum cotinine in national health surveys. The prevalence of secondhand smoke exposure among U.S. nonsmokers declined from 87.5% in 1988 to 25.2% in 2014. However, nearly half of black people and poor people were exposed in 2014.

Interventions to reduce environmental tobacco smoke

A systematic review compared smoking control programmes and their effects on smoke exposure in children. The review distinguishes between community-based, ill-child and healthy-child settings and the most common types of interventions were counselling or brief advice during clinical visits. The review did not find superior outcomes for any intervention, and the authors caution that evidence from adult settings may not generalise well to children.

Biomarkers

Environmental tobacco smoke can be evaluated either by directly measuring tobacco smoke pollutants found in the air or by using biomarkers, an indirect measure of exposure. Carbon monoxide monitored through breath, nicotine, cotinine, thiocyanates, and proteins are the most specific biological markers of tobacco smoke exposure. Biochemical tests are a much more reliable biomarker of secondhand smoke exposure than surveys. Certain groups of people are reluctant to disclose their smoking status and exposure to tobacco smoke, especially pregnant women and parents of young children. This is due to their smoking being socially unacceptable. Also, it may be difficult for individuals to recall their exposure to tobacco smoke.

A 2007 study in the Addictive Behaviors journal found a positive correlation between secondhand tobacco smoke exposure and concentrations of nicotine and/or biomarkers of nicotine in the body. Significant biological levels of nicotine from secondhand smoke exposure were equivalent to nicotine levels from active smoking and levels that are associated with behaviour changes due to nicotine consumption.

Cotinine

Cotinine, the metabolite of nicotine, is a biomarker of secondhand smoke exposure. Typically, cotinine is measured in the blood, saliva, and urine. Hair analysis has recently become a new, noninvasive measurement technique. Cotinine accumulates in hair during hair growth, which results in a measure of long-term, cumulative exposure to tobacco smoke. Urinary cotinine levels have been a reliable biomarker of tobacco exposure and have been used as a reference in many epidemiological studies. However, cotinine levels found in the urine reflect exposure only over the preceding 48 hours. Cotinine levels of the skin, such as the hair and nails, reflect tobacco exposure over the previous three months and are a more reliable biomarker.

Carbon monoxide (CO)

Carbon monoxide monitored via breath is also a reliable biomarker of secondhand smoke exposure as well as tobacco use. With high sensitivity and specificity, it not only provides an accurate measure, but the test is also non-invasive, highly reproducible, and low in cost. Breath CO monitoring measures the concentration of CO in an exhalation in parts per million, and this can be directly correlated to the blood CO concentration (carboxyhemoglobin). Breath CO monitors can also be used by emergency services to identify patients who are suspected of having CO poisoning.

Pathophysiology

A 2004 study by the International Agency for Research on Cancer of the World Health Organization concluded that non-smokers are exposed to the same carcinogens as active smokers. Sidestream smoke contains more than 4,000 chemicals, including 69 known carcinogens. Of special concern are polynuclear aromatic hydrocarbons, tobacco-specific N-nitrosamines, and aromatic amines, such as 4-aminobiphenyl, all known to be highly carcinogenic. Mainstream smoke, sidestream smoke, and secondhand smoke contain largely the same components, however the concentration varies depending on type of smoke.

Secondhand smoke has been shown to produce more particulate-matter (PM) pollution than an idling low-emission diesel engine. In an experiment conducted by the Italian National Cancer Institute, three cigarettes were left smoldering, one after the other, in a 60 m3 garage with a limited air exchange. The cigarettes produced PM pollution exceeding outdoor limits, as well as PM concentrations up to 10-fold that of the idling engine.

Secondhand tobacco smoke exposure has immediate and substantial effects on blood and blood vessels in a way that increases the risk of a heart attack, particularly in people already at risk. Exposure to tobacco smoke for 30 minutes significantly reduces coronary flow velocity reserve in healthy nonsmokers. Secondhand smoke is also associated with impaired vasodilation among adult nonsmokers. Secondhand smoke exposure also affects platelet function, vascular endothelium, and myocardial exercise tolerance at levels commonly found in the workplace.

Pulmonary emphysema can be induced in rats through acute exposure to sidestream tobacco smoke (30 cigarettes per day) over a period of 45 days. Degranulation of mast cells contributing to lung damage has also been observed.

The term "third-hand smoke" was recently coined to identify the residual tobacco smoke contamination that remains after the cigarette is extinguished and secondhand smoke has cleared from the air. Preliminary research suggests that by-products of third-hand smoke may pose a health risk, though the magnitude of risk, if any, remains unknown. In October 2011, it was reported that Christus St. Frances Cabrini Hospital in Alexandria, Louisiana, would seek to eliminate third-hand smoke beginning in July 2012, and that employees whose clothing smelled of smoke would not be allowed to work. This prohibition was enacted because third-hand smoke poses a special danger for the developing brains of infants and small children.

In 2008, there were more than 161,000 deaths attributed to lung cancer in the United States. Of these deaths, an estimated 10% to 15% were caused by factors other than first-hand smoking; equivalent to 16,000 to 24,000 deaths annually. Slightly more than half of the lung cancer deaths caused by factors other than first-hand smoking were found in nonsmokers. Lung cancer in non-smokers may well be considered one of the most common cancer mortalities in the United States. Clinical epidemiology of lung cancer has linked the primary factors closely tied to lung cancer in non-smokers as exposure to secondhand tobacco smoke, carcinogens including radon, and other indoor air pollutants.

Opinion of public health authorities

There is widespread scientific consensus that exposure to secondhand smoke is harmful. The link between passive smoking and health risks is accepted by every major medical and scientific organisation, including:

• World Health Organization
• U.S. National Institutes of Health
• Centers for Disease Control
• United States Surgeon General
• U.S. National Cancer Institute
• United States Environmental Protection Agency
• California Environmental Protection Agency
• American Heart Association, American Lung Association, and American Cancer Society
• American Medical Association
• American Academy of Pediatrics
• Australian National Health and Medical Research Council
• United Kingdom Scientific Committee on Tobacco and HealthTwo relevant reports have been published by the Scientific Committee:
• A 1998 report of the SCOTH concluded that passive smoking was a cause of lung cancer, heart disease, and other health problems.
• A 2004 update by the SCOTH , reviewing new evidence published since the 1998 report, found that recent research had confirmed the initially reported link between passive smoking and health risks.

Public opinion

Recent major surveys conducted by the U.S. National Cancer Institute and Centers for Disease Control have found widespread public awareness that secondhand smoke is harmful. In both 1992 and 2000 surveys, more than 80% of respondents agreed with the statement that secondhand smoke was harmful. A 2001 study found that 95% of adults agreed that secondhand smoke was harmful to children, and 96% considered tobacco-industry claims that secondhand smoke was not harmful to be untruthful.

A 2007 Gallup poll found that 56% of respondents felt that secondhand smoke was "very harmful", a number that has held relatively steady since 1997. Another 29% believe that secondhand smoke is "somewhat harmful"; 10% answered "not too harmful", while 5% said "not at all harmful".

Controversy over harm

As part of its attempt to prevent or delay tighter regulation of smoking, the tobacco industry funded a number of scientific studies and, where the results cast doubt on the risks associated with secondhand smoke, sought wide publicity for those results. The industry also funded libertarian and conservative think tanks, such as the Cato Institute in the United States and the Institute of Public Affairs in Australia which criticised both scientific research on passive smoking and policy proposals to restrict smoking. New Scientist and the European Journal of Public Health have identified these industry-wide coordinated activities as one of the earliest expressions of corporate denialism. Further, they state that the disinformation spread by the tobacco industry has created a tobacco denialism movement, sharing many characteristics of other forms of denialism, such as HIV-AIDS denialism.

Industry-funded studies and critiques

Enstrom and Kabat

A 2003 study by James Enstrom and Geoffrey Kabat, published in the British Medical Journal, argued that the harms of passive smoking had been overstated. Their analysis reported no statistically significant relationship between passive smoking and lung cancer, coronary heart disease (CHD), or chronic obstructive pulmonary disease, though the accompanying editorial noted that "they may overemphasise the negative nature of their findings." This paper was widely promoted by the tobacco industry as evidence that the harms of passive smoking were unproven. The American Cancer Society (ACS), whose database Enstrom and Kabat used to compile their data, criticized the paper as "neither reliable nor independent", stating that scientists at the ACS had repeatedly pointed out serious flaws in Enstrom and Kabat's methodology prior to publication. Notably, the study had failed to identify a comparison group of "unexposed" persons.

Enstrom's ties to the tobacco industry also drew scrutiny; in a 1997 letter to Philip Morris, Enstrom requested a "substantial research commitment... in order for me to effectively compete against the large mountain of epidemiologic data and opinions that already exist regarding the health effects of ETS and active smoking." In a US racketeering lawsuit against tobacco companies, the Enstrom and Kabat paper was cited by the US District Court as "a prime example of how nine tobacco companies engaged in criminal racketeering and fraud to hide the dangers of tobacco smoke." The Court found that the study had been funded and managed by the Center for Indoor Air Research, a tobacco industry front group tasked with "offsetting" damaging studies on passive smoking, as well as by Philip Morris who stated that Enstrom's work was "clearly litigation-oriented". A 2005 paper in Tobacco Control argued that the disclosure section in the Enstrom and Kabat BMJ paper, although it met the journal's requirements, "does not reveal the full extent of the relationship the authors had with the tobacco industry."

In 2006, Enstrom and Kabat published a meta-analysis of studies regarding passive smoking and coronary heart disease in which they reported a very weak association between passive smoking and heart disease mortality. They concluded that exposure to secondhand smoke increased the risk of death from CHD by only 5%, although this analysis has been criticized for including two previous industry-funded studies that suffered from widespread exposure misclassification.

Gori

Gio Batta Gori, a tobacco industry spokesman and consultant and an expert on risk utility and scientific research, wrote in the libertarian Cato Institute's magazine Regulation that "...of the 75 published studies of ETS and lung cancer, some 70% did not report statistically significant differences of risk and are moot. Roughly 17% claim an increased risk and 13% imply a reduction of risk."

Milloy

Steven Milloy, the "junk science" commentator for Fox News and a former Philip Morris consultant, claimed that "of the 19 studies" on passive smoking "only 8— slightly more than 42%— reported statistically significant increases in heart disease incidence."

Another component of criticism cited by Milloy focused on relative risk and epidemiological practices in studies of passive smoking. Milloy, who has a master's degree from the Johns Hopkins School of Hygiene and Public Health, argued that studies yielding relative risks of less than 2 were meaningless junk science. This approach to epidemiological analysis was criticized in the American Journal of Public Health:

The tobacco industry and affiliated scientists also put forward a set of "Good Epidemiology Practices" which would have the practical effect of obscuring the link between secondhand smoke and lung cancer; the privately stated goal of these standards was to "impede adverse legislation". However, this effort was largely abandoned when it became clear that no independent epidemiological organization would agree to the standards proposed by Philip Morris et al.

Levois and Layard

In 1995, Levois and Layard, both tobacco industry consultants, published two analyses in the journal Regulatory Toxicology and Pharmacology regarding the association between spousal exposure to secondhand smoke and heart disease. Both of these papers reported no association between secondhand smoke and heart disease. These analyses have been criticized for failing to distinguish between current and former smokers, despite the fact that former smokers, unlike current ones, are not at a significantly increased risk of heart disease.

World Health Organization controversy

A 1998 study by the International Agency for Research on Cancer (IARC) on environmental tobacco smoke (ETS) found "weak evidence of a dose–response relationship between risk of lung cancer and exposure to spousal and workplace ETS."

In March 1998, before the study was published, reports appeared in the media alleging that the IARC and the World Health Organization (WHO) were suppressing information. The reports, appearing in the British Sunday Telegraph and The Economist, among other sources, alleged that the WHO withheld from publication of its own report that supposedly failed to prove an association between passive smoking and a number of other diseases (lung cancer in particular).

In response, the WHO issued a press release stating that the results of the study had been "completely misrepresented" in the popular press and were in fact very much in line with similar studies demonstrating the harms of passive smoking. The study was published in the Journal of the National Cancer Institute in October of the same year, and concluded the authors found "no association between childhood exposure to ETS and lung cancer risk" but "did find weak evidence of a dose–response relationship between risk of lung cancer and exposure to spousal and workplace ETS." An accompanying editorial summarized:

With the release of formerly classified tobacco industry documents through the Tobacco Master Settlement Agreement, it was found (by Elisa Ong and Stanton Glantz) that the controversy over the WHO's alleged suppression of data had been engineered by Philip Morris, British American Tobacco, and other tobacco companies in an effort to discredit scientific findings which would harm their business interests. A WHO inquiry, conducted after the release of the tobacco-industry documents, found that this controversy was generated by the tobacco industry as part of its larger campaign to cut the WHO's budget, distort the results of scientific studies on passive smoking, and discredit the WHO as an institution. This campaign was carried out using a network of ostensibly independent front organizations and international and scientific experts with hidden financial ties to the industry.

EPA lawsuit

In 1993, the United States Environmental Protection Agency (EPA) issued a report estimating that 3,000 lung cancer related deaths in the United States were caused by passive smoking annually.

Philip Morris, R.J. Reynolds Tobacco Company, and groups representing growers, distributors and marketers of tobacco took legal action, claiming that the EPA had manipulated this study and ignored accepted scientific and statistical practices.

The United States District Court for the Middle District of North Carolina ruled in favor of the tobacco industry in 1998, finding that the EPA had failed to follow proper scientific and epidemiologic practices and had "cherry picked" evidence to support conclusions which they had committed to in advance. The court stated in part, "EPA publicly committed to a conclusion before research had begun...adjusted established procedure and scientific norms to validate the Agency's public conclusion... In conducting the ETS Risk Assessment, disregarded information and made findings on selective information; did not disseminate significant epidemiologic information; deviated from its Risk Assessment Guidelines; failed to disclose important findings and reasoning..."

In 2002, the EPA successfully appealed this decision to the United States Court of Appeals for the Fourth Circuit. The EPA's appeal was upheld on the preliminary grounds that their report had no regulatory weight, and the earlier finding was vacated.

In 1998, the U.S. Department of Health and Human Services, through the publication by its National Toxicology Program of the 9th Report on Carcinogens, listed environmental tobacco smoke among the known carcinogens, observing of the EPA assessment that "The individual studies were carefully summarized and evaluated."

Tobacco-industry funding of research

The tobacco industry's role in funding scientific research on secondhand smoke has been controversial. A review of published studies found that tobacco-industry affiliation was strongly correlated with findings exonerating secondhand smoke; researchers affiliated with the tobacco industry were 88 times more likely than independent researchers to conclude that secondhand smoke was not harmful. In a specific example which came to light with the release of tobacco-industry documents, Philip Morris executives successfully encouraged an author to revise his industry-funded review article to downplay the role of secondhand smoke in sudden infant death syndrome. The 2006 U.S. Surgeon General's report criticized the tobacco industry's role in the scientific debate:

This strategy was outlined at an international meeting of tobacco companies in 1988, at which Philip Morris proposed to set up a team of scientists, organized by company lawyers, to "carry out work on ETS to keep the controversy alive." All scientific research was subject to oversight and "filtering" by tobacco-industry lawyers:

|Philip Morris then expect the group of scientists to operate within the confines of decisions taken by PM scientists to determine the general direction of research, which apparently would then be 'filtered' by lawyers to eliminate areas of sensitivity.

Philip Morris reported that it was putting "...vast amounts of funding into these projects... in attempting to coordinate and pay so many scientists on an international basis to keep the ETS controversy alive."

Tobacco industry response

Measures to tackle secondhand smoke pose a serious economic threat to the tobacco industry, having broadened the definition of smoking beyond a personal habit to something with a social impact. In a confidential 1978 report, the tobacco industry described increasing public concerns about secondhand smoke as "the most dangerous development to the viability of the tobacco industry that has yet occurred." In United States of America v. Philip Morris et al., the District Court for the District of Columbia found that the tobacco industry "... recognized from the mid-1970s forward that the health effects of passive smoking posed a profound threat to industry viability and cigarette profits," and that the industry responded with "efforts to undermine and discredit the scientific consensus that ETS causes disease."

Accordingly, the tobacco industry have developed several strategies to minimise the impact on their business:

• The industry has sought to position the secondhand smoke debate as essentially concerned with civil liberties and smokers' rights rather than with health, by funding groups such as FOREST.
• Funding bias in research; in all reviews of the effects of secondhand smoke on health published between 1980 and 1995, the only factor associated with concluding that secondhand smoke is not harmful was whether an author was affiliated with the tobacco industry. However, not all studies that failed to find evidence of harm were by industry-affiliated authors.
• Delaying and discrediting legitimate research (see for an example of how the industry attempted to discredit Takeshi Hirayama's landmark study, and for an example of how it attempted to delay and discredit a major Australian report on passive smoking)
• Promoting "good epidemiology" and attacking so-called junk science (a term popularised by industry lobbyist Steven Milloy): attacking the methodology behind research showing health risks as flawed and attempting to promote sound science. Ong & Glantz (2001) cite an internal Phillip Morris memo giving evidence of this as company policy.
• Creation of outlets for favourable research. In 1989, the tobacco industry established the International Society of the Built Environment, which published the peer-reviewed journal Indoor and Built Environment. This journal did not require conflict-of-interest disclosures from its authors. With documents made available through the Master Settlement, it was found that the executive board of the society and the editorial board of the journal were dominated by paid tobacco-industry consultants. The journal published a large amount of material on passive smoking, much of which was "industry-positive".

Citing the tobacco industry's production of biased research and efforts to undermine scientific findings, the 2006 U.S. Surgeon General's report concluded that the industry had "attempted to sustain controversy even as the scientific community reached consensus... industry documents indicate that the tobacco industry has engaged in widespread activities... that have gone beyond the bounds of accepted scientific practice." The U.S. District Court, in U.S.A. v. Philip Morris et al., found that "...despite their internal acknowledgment of the hazards of secondhand smoke, Defendants have fraudulently denied that ETS causes disease."

Position of major tobacco companies

The positions of major tobacco companies on the issue of secondhand smoke is somewhat varied. In general, tobacco companies have continued to focus on questioning the methodology of studies showing that secondhand smoke is harmful. Some (such as British American Tobacco and Philip Morris) acknowledge the medical consensus that secondhand smoke carries health risks, while others continue to assert that the evidence is inconclusive. Several tobacco companies advocate the creation of smoke-free areas within public buildings as an alternative to comprehensive smoke-free laws.The most current positions of major tobacco companies on the issue of passive smoking can be found on their websites. As of 13 January 2009, the following websites contain tobacco-industry positions on the topic:

• British American Tobacco: http://www.bat.com/group/sites/uk__3mnfen.nsf/vwPagesWebLive/DO52AMJ4
• Imperial Tobacco:
• Philip Morris: USA and International
• R. J. Reynolds Tobacco Company:

US racketeering lawsuit against tobacco companies

On September 22, 1999, the U.S. Department of Justice filed a racketeering lawsuit against Philip Morris and other major cigarette manufacturers. Almost 7 years later, on August 17, 2006, U.S. District Court Judge Gladys Kessler found that the Government had proven its case and that the tobacco company defendants had violated the Racketeer Influenced Corrupt Organizations Act (RICO). In particular, Judge Kessler found that PM and other tobacco companies had:

• conspired to minimize, distort and confuse the public about the health hazards of smoking;
• publicly denied, while internally acknowledging, that secondhand tobacco smoke is harmful to nonsmokers, and
• destroyed documents relevant to litigation.

The ruling found that tobacco companies undertook joint efforts to undermine and discredit the scientific consensus that secondhand smoke causes disease, notably by controlling research findings via paid consultants. The ruling also concluded that tobacco companies were fraudulently continuing to deny the health effects of ETS exposure.

On May 22, 2009, a three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit unanimously upheld the lower court's 2006 ruling.

Smoke-free laws

As a consequence of the health risks associated with secondhand smoke, many national and local governments have outlawed smoking in indoor public places, including restaurants, cafés, and nightclubs, as well as some outdoor open areas. Ireland was the first country in the world to institute a comprehensive national ban on smoking in all indoor workplaces on 29 March 2004. Since then, many others have followed suit. The countries which have ratified the WHO Framework Convention on Tobacco Control (FCTC) have a legal obligation to implement effective legislation "for protection from exposure to tobacco smoke in indoor workplaces, public transport, indoor public places and, as appropriate, other public places." (Article 8 of the FCTC) The parties to the FCTC have further adopted Guidelines on the Protection from Exposure to secondhand Smoke which state that "effective measures to provide protection from exposure to tobacco smoke ... require the total elimination of smoking and tobacco smoke in a particular space or environment in order to create a 100% smoke-free environment."

Opinion polls have shown considerable support for smoke-free laws. In June 2007, a survey of 15 countries found 80% approval for such laws. A survey in France, reputedly a nation of smokers, showed 70% support.

Effects

Smoking bans by governments result in decreased harm from secondhand smoke, including less admissions for acute coronary syndrome. In the first 18 months after the town of Pueblo, Colorado, enacted a smoke-free law in 2003, hospital admissions for heart attacks dropped 27%. Admissions in neighbouring towns without smoke-free laws showed no change, and the decline in heart attacks in Pueblo was attributed to the resulting reduction in secondhand smoke exposure. A 2004 smoking ban instituted in Massachusetts workplaces decreased workers' secondhand smoke exposure from 8% of workers in 2003 to 5.4% of workers in 2010. A 2016 review also found that bans and policy changes in specific locations such as hospitals or universities can lead to reduced smoking rates. In prison settings bans might lead to reduced mortality and to lower exposure to secondhand smoke.

In 2001, a systematic review for the Guide to Community Preventive Services acknowledged strong evidence of the effectiveness of smoke-free policies and restrictions in reducing expose to secondhand smoke. A follow-up to this review, identified the evidence on which the effectiveness of smoking bans reduced the prevalence of tobacco use. Articles published until 2005, were examined to further support this evidence. The examined studies provided sufficient evidence that smoke-free policies reduce tobacco use among workers when implemented in worksites or by communities.

While a number of studies funded by the tobacco industry have claimed a negative economic impact from smoke-free laws, no independently funded research has shown any such impact. A 2003 review reported that independently funded, methodologically sound research consistently found either no economic impact or a positive impact from smoke-free laws.

Air nicotine levels were measured in Guatemalan bars and restaurants before and after an implemented smoke-free law in 2009. Nicotine concentrations significantly decreased in both the bars and restaurants measured. Also, the employees' support for a smoke-free workplace substantially increased in the post-implementation survey compared to pre-implementation survey.

Public opinion

Recent surveys taken by the Society for Research on Nicotine and Tobacco demonstrate supportive attitudes of the public towards smoke-free policies in outdoor areas. A vast majority of the public supports restricting smoking in various outdoor settings. The respondents' support for the policies were for varying reasons such as litter control, establishing positive smoke-free role models for youth, reducing youth opportunities to smoke, and avoiding exposure to secondhand smoke.

Alternative forms

Alternatives to smoke-free laws have also been proposed as a means of harm reduction, particularly in bars and restaurants. For example, critics of smoke-free laws cite studies suggesting ventilation as a means of reducing tobacco smoke pollutants and improving air quality. Ventilation has also been heavily promoted by the tobacco industry as an alternative to outright bans, via a network of ostensibly independent experts with often undisclosed ties to the industry. However, not all critics have connections to the industry.

The American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) officially concluded in 2005 that while completely isolated smoking rooms do eliminate the risk to nearby non-smoking areas, smoking bans are the only means of eliminating health risks associated with indoor exposure. They further concluded that no system of dilution or cleaning was effective at eliminating risk. The U.S. Surgeon General and the European Commission Joint Research Centre have reached similar conclusions. The implementation guidelines for the WHO Framework Convention on Tobacco Control states that engineering approaches, such as ventilation, are ineffective and do not protect against secondhand smoke exposure. However, this does not necessarily mean that such measures are useless in reducing harm, only that they fall short of the goal of reducing exposure completely to zero.

Others have suggested a system of tradable smoking pollution permits, similar to the cap-and-trade pollution permits systems used by the United States Environmental Protection Agency in recent decades to curb other types of pollution. This would guarantee that a portion of bars/restaurants in a jurisdiction will be smoke-free, while leaving the decision to the market.

In animals

Main article: Animals and tobacco smoke

Multiple studies have been conducted to determine the carcinogenicity of environmental tobacco smoke to animals. These studies typically fall under the categories of simulated environmental tobacco smoke, administering condensates of sidestream smoke, or observational studies of cancer among pets.

To simulate environmental tobacco smoke, scientists expose animals to sidestream smoke, that which emanates from the cigarette's burning cone and through its paper, or a combination of mainstream and sidestream smoke. The IARC monographs conclude that mice with prolonged exposure to simulated environmental tobacco smoke, that is six hours a day, five days a week, for five months with a subsequent four-month interval before dissection, will have significantly higher incidence and multiplicity of lung tumors than with control groups.

The IARC monographs concluded that sidestream smoke condensates had a significantly higher carcinogenic effect on mice than did mainstream smoke condensates.

Observational studies

Secondhand smoke is popularly recognised as a risk factor for cancer in pets. A study conducted by the Tufts University School of Veterinary Medicine and the University of Massachusetts Amherst linked the occurrence of feline oral cancer to exposure to environmental tobacco smoke through an overexpression of the p53 gene. Another study conducted at the same universities concluded that cats living with a smoker were more likely to get feline lymphoma; the risk increased with the duration of exposure to secondhand smoke and the number of smokers in the household. A study by Colorado State University researchers, looking at cases of canine lung cancer, was generally inconclusive, though the authors reported a weak relation for lung cancer in dogs exposed to environmental tobacco smoke. The number of smokers within the home, the number of packs smoked in the home per day, and the amount of time that the dog spent within the home had no effect on the dog's risk for lung cancer.

References

References

1. (2006-06-27). "The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General". [[Surgeon General of the United States]].
2. {{harvnb. IARC. 2004 [http://monographs.iarc.fr/ENG/Monographs/vol83/index.php "There is sufficient evidence that involuntary smoking (exposure to secondhand or 'environmental' tobacco smoke) causes lung cancer in humans"]
3. "Tobacco".
4. Samet JM. (2008). "Secondhand smoke: facts and lies". Salud Pública de México.
5. "CDC - Fact Sheet - Smoke-Free Policies Reduce Smoking - Smoking & Tobacco Use".
6. (2006). "Lifting the smokescreen: tobacco industry strategy to defeat smoke free policies and legislation".
7. (16 October 2007). "Tobacco Industry Efforts Undermining Evidence Linking Secondhand Smoke With Cardiovascular Disease". Circulation.
8. Gourd, Katherine. (2014). "Fritz Lickint". [[The Lancet]].
9. . (2017). ["Chapter 32 History of Tobacco"](https://www.afro.who.int/sites/default/files/2017-09/Chapter%2032.%20The%20history%20of%20tobacco.pdf). *[[World Health Organization]]*.
10. (18 November 2013). "The first surgeon general's report on smoking and health: The 50th anniversary". CA.
11. "Health Effects of Exposure to Secondhand Smoke". United States Environmental Protection Agency.
12. (1 June 2003). "Other people's smoke: what's in a name?". Tobacco Control.
13. (1 October 2011). "The New Danger of Thirdhand Smoke: Why Passive Smoking Does Not Stop at Secondhand Smoke". Environmental Health Perspectives.
14. {{harvnb. IARC. 2004
15. (24 June 2005). "Proposed Identification of Environmental Tobacco Smoke as a Toxic Air Contaminant".
16. {{harvnb. Surgeon General. 2006
17. (1 May 2013). "Epidemiology of Lung Cancer". Chest.
18. (14 October 2014). "Electronic cigarettes: a policy statement from the American Heart Association". Circulation.
19. (November 24, 2014). "Health Effects of Secondhand Smoke".
20. (December 2013). "Lung cancer in never smokers: Disease characteristics and risk factors". Critical Reviews in Oncology/Hematology.
21. (September 2016). "The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks". European Urology.
22. {{harvnb. Surgeon General. 2006
23. (15 November 2015). "Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: a systematic review and meta-analysis". International Journal of Cardiology.
24. (20 February 2013). "Effects of active and passive tobacco cigarette smoking on heart rate variability". International Journal of Cardiology.
25. (20 February 2009). "Passive cigarette smoking induces inflammatory injury in human arterial walls". Chinese Medical Journal.
26. (December 2011). "Meta-analysis of the association between secondhand smoke exposure and stroke". Journal of Public Health.
27. {{harvnb. Surgeon General. 2006
28. (6 December 2013). "Indoor air pollution and respiratory health in the elderly". Journal of Environmental Science and Health, Part A.
29. (November 2015). "Second-hand smoke and the risk of tuberculosis: a systematic review and a meta-analysis". Epidemiology and Infection.
30. (January 2014). "The role of secondhand smoke in sinusitis: a systematic review: Sinusitis and secondhand smoke". [[International Forum of Allergy & Rhinology]].
31. (December 2013). "Association of passive smoking with cognitive impairment in nonsmoking older adults: a systematic literature review and a new study of Chinese cohort". Journal of Geriatric Psychiatry and Neurology.
32. (24 March 2016). "The Cognitive Deficits Associated with Second-Hand Smoking". Frontiers in Psychiatry.
33. (10 December 2015). "Secondhand smoke exposure and mental health in adults: a meta-analysis of cross-sectional studies". Social Psychiatry and Psychiatric Epidemiology.
34. (10 February 2014). "Systematic Review and Meta-Analysis of Miscarriage and Maternal Exposure to Tobacco Smoke During Pregnancy". American Journal of Epidemiology.
35. {{harvnb. Surgeon General. 2006
36. (25 January 2016). "Associations between Passive Maternal Smoking during Pregnancy and Preterm Birth: Evidence from a Meta-Analysis of Observational Studies". PLOS ONE.
37. {{harvnb. Surgeon General. 2006
38. (28 March 2014). "Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis". Lancet.
39. (April 2011). "Secondhand smoke and adverse fetal outcomes in nonsmoking pregnant women: a meta-analysis". Pediatrics.
40. (2010). "Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses". Acta Obstet Gynecol Scand.
41. (13 August 2013). "Maternal passive smoking during pregnancy and neural tube defects in offspring: a meta-analysis". Archives of Gynecology and Obstetrics.
42. Janson C. (2004). "The effect of passive smoking on respiratory health in children and adults". Int J Tuberc Lung Dis.
43. (11 March 2014). "Active or Passive Exposure to Tobacco Smoking and Allergic Rhinitis, Allergic Dermatitis, and Food Allergy in Adults and Children: A Systematic Review and Meta-Analysis". PLOS Medicine.
44. (January 2015). "A meta-analysis of passive smoking and risk of developing Type 2 Diabetes Mellitus". Diabetes Research and Clinical Practice.
45. (2013). "Passive smoking and risk of type 2 diabetes: a meta-analysis of prospective cohort studies". PLOS ONE.
46. (November 2014). "Passive smoke exposure and risk of diabetes: a meta-analysis of prospective studies". Endocrine.
47. (December 2015). "Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis". The Lancet Diabetes & Endocrinology.
48. (November 2016). "Systematic Review and Meta-analysis of the Association Between Exposure to Environmental Tobacco Smoke and Periodontitis Endpoints Among Nonsmokers". Nicotine & Tobacco Research.
49. (1991). "Passive smoking and heart disease. Epidemiology, physiology, and biochemistry". Circulation.
50. (1992). "Environmental tobacco smoke and cardiovascular disease. A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association". Circulation.
51. {{harvnb. Surgeon General. 2006
52. "Second-hand smoke".
53. (19 July 2017). "The last gasp". [[The Economist]].
54. (December 2016). "Association of atopic dermatitis with smoking: A systematic review and meta-analysis". Journal of the American Academy of Dermatology.
55. (November 1997). "Passive smoking and sudden infant death syndrome: review of the epidemiological evidence". Thorax.
56. {{harvnb. Surgeon General. 2006
57. (August 2006). "Secondhand Smoke and Children Fact Sheet". American Lung Association.
58. {{harvnb. Surgeon General. 2006
59. (2007). "Developing Asthma in Childhood from Exposure to Secondhand Tobacco Smoke: Insights from a Meta-Regression". [[Environ. Health Perspect.]].
60. (28 March 2013). "Meta-Analysis of the Association Between Secondhand Smoke Exposure and Physician-Diagnosed Childhood Asthma". Nicotine & Tobacco Research.
61. (November 2015). "Effects of secondhand smoke exposure on asthma morbidity and health care utilization in children: a systematic review and meta-analysis". Annals of Allergy, Asthma & Immunology.
62. (2003). "Cough • 2: Chronic cough in children". Thorax.
63. (1999). "Passive smoking, sudden infant death syndrome (SIDS) and childhood infections". Hum Exp Toxicol.
64. (2004). "Prenatal and postnatal environmental tobacco smoke exposure and children's health". [[Pediatrics (journal).
65. (July 2007). "Preventing Smoking and Exposure to Secondhand Smoke Before, During, and After Pregnancy". Centers for Disease Control and Prevention.
66. (June 2007). "The role of breastfeeding and passive smoking on the development of severe bronchiolitis in infants". Minerva Pediatrica.
67. (May 2015). "Childhood tuberculosis and exposure to indoor air pollution: a systematic review and meta-analysis". The International Journal of Tuberculosis and Lung Disease.
68. (November 2014). "Environmental tobacco smoke exposure and risk of allergic sensitisation in children: a systematic review and meta-analysis". Archives of Disease in Childhood.
69. (2015). "Passive smoking in the etiology of non-syndromic orofacial clefts: a systematic review and meta-analysis". PLOS ONE.
70. (July 2014). "Environmental tobacco smoke exposure and brain development: The case of attention deficit/hyperactivity disorder". [[Neuroscience & Biobehavioral Reviews]].
71. (July 1, 2008). "Scientific Consensus Statement on Environmental Agents Associated with Neurodevelopmental Disorders". The Collaborative on Health and the Environment's Learning and Developmental Disabilities Initiative.
72. (October 2013). "Is exposure to secondhand smoke associated with cognitive parameters of children and adolescents?—a systematic literature review". Annals of Epidemiology.
73. {{harvnb. Surgeon General. 2006
74. (1 January 2012). "Parental Smoking and the Risk of Middle Ear Disease in Children: A Systematic Review and Meta-analysis". Archives of Pediatrics & Adolescent Medicine.
75. (7 December 2010). "Association of Secondhand Smoke Exposure with Pediatric Invasive Bacterial Disease and Bacterial Carriage: A Systematic Review and Meta-analysis". PLOS Medicine.
76. (7 December 2010). "Association of Secondhand Smoke Exposure with Pediatric Invasive Bacterial Disease and Bacterial Carriage: A Systematic Review and Meta-analysis". PLOS Medicine.
77. (February 2017). "Impact of environmental tobacco smoke exposure on anaesthetic and surgical outcomes in children: a systematic review and meta-analysis". Archives of Disease in Childhood.
78. (January 2015). "The association between secondhand smoke and sleep-disordered breathing in children: a systematic review". The Laryngoscope.
79. (18 October 2016). "Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association". Circulation.
80. (1 January 1992). "Passive smoking and the risk of heart disease". JAMA.
81. (18 October 1997). "Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence". BMJ.
82. (December 1999). "Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking". Environmental Health Perspectives.
83. (25 March 1999). "Passive Smoking and the Risk of Coronary Heart Disease — A Meta-Analysis of Epidemiologic Studies". New England Journal of Medicine.
84. (2005). "The whole truth and nothing but the truth? The research that Philip Morris did not want you to see". Lancet.
85. (2005). "Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke". Tobacco Control.
86. (2006). "Sidestream cigarette smoke toxicity increases with aging and exposure duration". Tobacco Control.
87. (1 August 2007). "Concentrations of the Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Sidestream Cigarette Smoke Increase after Release into Indoor Air: Results from Unpublished Tobacco Industry Research". Cancer Epidemiology, Biomarkers & Prevention.
88. (24 July 2004). "Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement". BMJ.
89. (18 October 1997). "The accumulated evidence on lung cancer and environmental tobacco smoke". BMJ.
90. (12 February 2000). "Reanalysis of epidemiological evidence on lung cancer and passive smoking". BMJ.
91. (January 2000). "Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis". Lung Cancer.
92. (June 2001). "Passive smoking and lung cancer: a cumulative meta-analysis". Australian and New Zealand Journal of Public Health.
93. (15 October 2014). "Exposure to secondhand tobacco smoke and lung cancer by histological type: A pooled analysis of the International Lung Cancer Consortium (ILCCO): Secondhand tobacco smoke and lung cancer". International Journal of Cancer.
94. Novak K. (2007). "Passive smoking: out from the haze". Nature.
95. (25 March 1999). "Passive Smoking, Coronary Heart Disease, and Meta-Analysis". New England Journal of Medicine.
96. (1 February 2006). "Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm". European Heart Journal.
97. (1 October 2007). "Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent". International Journal of Epidemiology.
98. (March 2007). "Lung Cancer Risk and Workplace Exposure to Environmental Tobacco Smoke". American Journal of Public Health.
99. "Health effects of indoor air pollution".
100. (March 2005). "Le tabagisme passif". Revue de Pneumologie Clinique.
101. (2006-10-08). "France to ban smoking in public". [[BBC]].
102. (September 2009). "Cardiovascular Effect of Bans on Smoking in Public Places". Journal of the American College of Cardiology.
103. (December 2013). "The effects of smoke-free legislation on acute myocardial infarction: a systematic review and meta-analysis". BMC Public Health.
104. (2006). "The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General". Centers for Disease Control and Prevention (US).
105. (February 2017). "Environmental tobacco smoke exposure among infants, children and young people: now is no time to relax". Archives of Disease in Childhood.
106. (October 1997). "Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood". Thorax.
107. (1 January 1998). "Health effects of passive smoking. 4. Parental smoking, middle ear disease and adenotonsillectomy in children". Thorax.
108. (December 2009). "Perceptions of Second-hand Smoke Risks Predict Future Adolescent Smoking Initiation". Journal of Adolescent Health.
109. "WHO Framework Convention on Tobacco Control (WHO FCTC)".
110. (7 December 2018). "Exposure to Secondhand Smoke Among Nonsmokers — United States, 1988–2014". MMWR. Morbidity and Mortality Weekly Report.
111. (31 January 2018). "Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke". Cochrane Database of Systematic Reviews.
112. (February 2005). "[Markers of environmental tobacco smoke (ETS) exposure]". Rev Mal Respir.
113. McClure JB. (April 2002). "Are biomarkers useful treatment aids for promoting health behavior change? An empirical review". Am J Prev Med.
114. (October 1995). "Are self-reports of smoking rate biased? Evidence from the Second National Health and Nutrition Examination Survey". J Clin Epidemiol.
115. (October 2007). "Secondhand smoke and nicotine exposure: a brief review". Addict Behav.
116. (February 2009). "Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology". Ther Drug Monit.
117. (January 1988). "Evaluation of a portable measure of expired-air carbon monoxide". Prev Med.
118. (2004). "Particulate matter from tobacco versus diesel car exhaust: an educational perspective". Tob Control.
119. (2005). "Cardiovascular effects of secondhand smoke: nearly as large as smoking". Circulation.
120. (2001). "Acute effects of passive smoking on the coronary circulation in healthy young adults". JAMA.
121. (18 January 1996). "Passive Smoking and Impaired Endothelium-Dependent Arterial Dilatation in Healthy Young Adults". New England Journal of Medicine.
122. (December 1999). "Why is environmental tobacco smoke more strongly associated with coronary heart disease than expected? A review of potential biases and experimental data". Environmental Health Perspectives.
123. (October 1997). "Pulmonary emphysema induced by passive smoking: an experimental study in rats". Brazilian Journal of Medical and Biological Research.
124. (2006). "Effects of long-term passive smoking on the mast cells in rat lungs". Revue de Médecine Vétérinaire.
125. (March 2004). "Households contaminated by environmental tobacco smoke: sources of infant exposures". Tob Control.
126. (January 2009). "Beliefs about the health effects of "thirdhand" smoke and home smoking bans". Pediatrics.
127. Rabin, Roni Caryn. (2009-01-02). "A New Cigarette Hazard: 'Third-Hand Smoke'". [[New York Times]].
128. (13 April 2010). "Formation of carcinogens indoors by surface-mediated reactions of nicotine with nitrous acid, leading to potential thirdhand smoke hazards". Proceedings of the National Academy of Sciences.
129. [https://www.foxnews.com/us/louisiana-hospital-to-ban-odor-of-smoke-on-workers-clothes/ Louisiana Hospital to Ban Odor of Smoke on Workers' Clothes], Fox News, October 3, 2011
130. (15 September 2009). "Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors". Clinical Cancer Research.
131. {{harvnb. Kessler. 2006
132. "Environmental Tobacco Smoke". U.S. [[National Institutes of Health]].
133. (2017-02-21). "Secondhand Smoke Fact Sheet". U.S. [[Centers for Disease Control and Prevention]].
134. "Health Effects of Exposure to Environmental Tobacco Smoke". U.S. [[National Cancer Institute]].
135. "Health Effects of Exposure to Secondhand Smoke". [[United States Environmental Protection Agency]].
136. "The Truth about Secondhand Smoke". [[American Heart Association]].
137. "Secondhand Smoke Fact Sheet". [[American Lung Association]].
138. "Secondhand Smoke". [[American Cancer Society]].
139. "AMA: Surgeon General's secondhand smoke report a wake-up call to lawmakers". [[American Medical Association]].
140. "Tobacco's Toll: Implications for the Pediatrician". [[American Academy of Pediatrics]].
141. (November 2000). "National Response to Passive Smoking in Enclosed Public Places and Workplaces". Australian National Public Health Partnership.
142. {{harvnb. Surgeon General. 2006
143. Saad, Lydia. (25 July 2007). "More Smokers Feeling Harassed by Smoking Bans".
144. "[http://www.sourcewatch.org/index.php?title=Cato_Institute#Cato_and_the_tobacco_industry Cato and the tobacco industry]". Accessed 8 April 2011.
145. Nahan, Mike. ''The Australian'', 10 April 2000, "The IPA sings its own song".
146. (May 2010). "I am a sceptic, but I'm not a denier". New Scientist.
147. (16 October 2008). "Denialism: what is it and how should scientists respond?". The European Journal of Public Health.
148. (2003). "Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960-98". BMJ.
149. Davey Smith G. (2003). "Effect of passive smoking on health: More information is available, but the controversy still persists". BMJ.
150. {{harvnb. Kessler. 2006
151. (2007). "Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease". Circulation.
152. (2003-05-13). "American Cancer Society Condemns Tobacco Industry Study for Inaccurate Use of Data". [[American Cancer Society]].
153. (4 October 2003). "More misleading science from the tobacco industry". BMJ.
154. (1997-01-01). "Proposed Research on the relationship of Low Levels of Active Smoking to Mortality: Letter from James Enstrom to Philip Morris Scientific Affairs office".
155. Dalton R. (March 2007). "Passive-smoking study faces review". Nature.
156. {{harvnb. Kessler. 2006
157. {{harvnb. Kessler. 2006
158. (April 2005). "The limits of competing interest disclosures". Tobacco Control.
159. (March 2006). "Environmental tobacco smoke and coronary heart disease mortality in the United States--a meta-analysis and critique". Inhalation Toxicology.
160. {{harvnb. Kessler. 2006
161. [http://www.usdoj.gov/civil/cases/tobacco2/20040816%20US%20FACTUAL%20MEMO%20w%20BkMks.pdf United States of America v. Philip Morris et al.], United States Factual Memorandum Pursuant to Order No. 470, Section V, United States District Court for the District of Columbia. p. 44
162. [http://legacy.library.ucsf.edu/tid/hxh70e00 ETS / IAQ SCIENTIFIC CONSULTANTS], from the Legacy Tobacco Documents Archive. Retrieved July 19, 2007.
163. Gori, Gio Batta. (Spring 2007). "Stoking the Rigged Terror of Secondhand Smoke". Regulation.
164. [https://ssl.tnr.com/p/docsub.mhtml?i=20060206&s=thacker020606 Smoked Out: Pundit for Hire], by Paul D. Thacker. Published in ''[[The New Republic]]'' on January 26, 2006. Retrieved August 22, 2007.
165. [http://legacy.library.ucsf.edu/tid/kwk84a00 Philip Morris budget for "Strategy and Social Responsibility"], listing Milloy as a paid consultant. Retrieved August 22, 2007.
166. [http://www.junksciencearchive.com/news/bmjsmoke.html "Secondhand Joking"], by [[Steven Milloy]]. Retrieved May 31, 2013.
167. (2001). "Turning Science Into Junk: The Tobacco Industry and Passive Smoking". Am J Public Health.
168. (March 2018). "Constructing 'Sound Science' and 'Good Epidemiology': Tobacco, Lawyers, and Public Relations Firms". American Journal of Public Health.
169. (2001). "Constructing "Sound Science" and "Good Epidemiology": Tobacco, Lawyers, and Public Relations Firms". Am J Public Health.
170. (February 1995). "Ischemic Heart Disease and Spousal Smoking in the National Mortality Followback Survey". Regulatory Toxicology and Pharmacology.
171. (February 1995). "Publication Bias in the Environmental Tobacco Smoke/Coronary Heart Disease Epidemiologic Literature". Regulatory Toxicology and Pharmacology.
172. (July 2003). "Environmental tobacco smoke and ischemic heart disease". Progress in Cardiovascular Diseases.
173. (7 October 1998). "Multicenter Case-Control Study of Exposure to Environmental Tobacco Smoke and Lung Cancer in Europe". JNCI: Journal of the National Cancer Institute.
174. "Passive Smoking Doesn't Cause Cancer —Official".
175. "Smokescreens – The World Health Organization is showing signs of allowing politics to get in the way of truth. The Economist March 14th, 1998".
176. Le Grand C. Anti-smokers blown away by study. Australian 1998, March 10.
177. WHO Rejects smoking link with lung cancer. Zimbabwe Independent 1998, Oct 23.
178. No Link Between Passive Smoking and Lung Cancer. [[The Times]] 1998, March 9.
179. (June 1998). "Passive smoking does cause lung cancer, do not let them fool you". The Ceylon Medical Journal.
180. (7 October 1998). "Passive Smoking and Lung Cancer Risk: What Is the Story Now?". JNCI: Journal of the National Cancer Institute.
181. (2000). "Tobacco industry efforts subverting International Agency for Research on Cancer's second-hand smoke study". Lancet.
182. "Tobacco Companies Strategies to Undermine Tobacco Control Activities at the World Health Organization".
183. "Respiratory health effects of passive smoking: Lung cancer and other disorders".
184. "The Osteen Decision".
185. "Flue-Cured Tobacco Cooperative vs. EPA".
186. (December 2–3, 1998). "Meeting of the NTP Board of Scientific Counselors – Report on Carcinogens Subcommittee".
187. Thun MJ. (2003). "Passive smoking: Tobacco industry publishes disinformation". BMJ.
188. (1998). "Why review articles on the health effects of passive smoking reach different conclusions". JAMA.
189. (2005). "Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry". Pediatrics.
190. (2006). "The Health Consequences of Involuntary Exposure to Tobacco Smoke". [[Surgeon General of the United States]].
191. "Minutes of a meeting of Philip Morris with British tobacco companies to discuss tobacco-industry strategy on passive smoking".
192. [http://legacy.library.ucsf.edu/tid/qra99d00 A Study of Public Attitudes toward Cigarette Smoking and the Tobacco Industry in 1978], produced for the Tobacco Institute and released under the terms of the [[Tobacco Master Settlement Agreement]].
193. (5 January 2007). "'We will speak as the smoker': the tobacco industry's smokers' rights groups". The European Journal of Public Health.
194. (2003). ""Conclusions about exposure to ETS and health that will be unhelpful to us"*: How the tobacco industry attempted to delay and discredit the 1997 Australian National Health and Medical Research Council report on passive smoking". Tob Control.
195. (2005). "Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry". Lancet.
196. {{harvnb. Kessler. 2006
197. [http://www.usdoj.gov/civil/cases/tobacco2/index.htm Litigation Against Tobacco Companies] U.S. Department of Justice
198. [http://pacer.cadc.uscourts.gov/common/opinions/200905/06-5267-1181914.pdf Appeal Ruling], U.S. Court of Appeals for the District of Columbia Circuit, 22 May 2009
199. [https://www.bloomberg.com/apps/news?pid=newsarchive&sid=aTHJN4mM4M3I Altria, Cigarette Makers Lose 'Lights' Ruling Appeal] Bloomberg news, 22 May 2009
200. [https://www.reuters.com/article/domesticNews/idUSTRE54L44820090522?pageNumber=2&virtualBrandChannel=10531&sp=true U.S. appeals court agrees tobacco companies lied] Reuters, 22 May 2009
201. [http://gothamist.com/2011/05/18/smokers_just_daring_bloomberg_to_ti.php Smokers Daring Bloomberg To Ticket Them Under Park Ban] {{webarchive. link. (2013-11-26)
202. (2005-02-27). "WHO Framework Convention on Tobacco Control". [[World Health Organization]].
203. (2007). "Guidelines on the Protection from Exposure to Secondhand Smoke". [[World Health Organization]].
204. [http://www.marketresearchworld.net/index.php?option=content&task=view&id=1619&Itemid= Market Research World]
205. (4 February 2016). "Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption". Cochrane Database of Systematic Reviews.
206. (January 2009). "Reduced hospitalizations for acute myocardial infarction after implementation of a smoke-free ordinance—City of Pueblo, Colorado, 2002–2006". MMWR Morb. Mortal. Wkly. Rep..
207. Fitzsimmons, Kathleen. (21 November 2013). "Reducing Worker Exposure to ETS". National Institute for Occupational Safety and Health (NIOSH).
208. (27 May 2016). "Impact of institutional smoking bans on reducing harms and secondhand smoke exposure". Cochrane Database of Systematic Reviews.
209. (2010). "Smokefree policies to reduce tobacco use. A systematic review". Am J Prev Med.
210. (Mar 2003). "Review of the quality of studies on the economic effects of smoke-free policies on the hospitality industry". Tobacco Control.
211. (November 2010). "Secondhand smoke exposure in bars and restaurants in Guatemala City: before and after smoking ban evaluation". Cancer Causes Control.
212. (June 2009). "At the frontier of tobacco control: A brief review of public attitudes toward smoke-free outdoor places". Nicotine & Tobacco Research.
213. (7 March 2005). "No ifs or butts". Building.
214. (March 2004). "Tobacco industry efforts to present ventilation as an alternative to smoke-free environments in North America". Tob Control.
215. (July 2020). "ASHRAE Position Document on Environmental Tobacco Smoke". [[American Society of Heating, Refrigerating and Air-Conditioning Engineers]].
216. (2006). "The Health Consequences of Involuntary Exposure to Tobacco Smoke". [[Surgeon General of the United States]].
217. (2003). "Institute for Health and Consumer Protection Activity Report 2003". [[European Commission]] [[Joint Research Centre]].
218. Haveman, Robert. (September 25, 2005). "Let Bars Buy, Sell Smoking Permits". [[Wisconsin State Journal]].
219. Thompson, Andrea. (2007-08-31). "Secondhand Smoke Causes Cancer in Pets". LiveScience.
220. (2004). "p53 expression and environmental tobacco smoke exposure in feline oral squamous cell carcinoma". Vet Pathol.
221. (2002). "Environmental Tobacco Smoke and Risk of Malignant Lymphoma in Pet Cats". American Journal of Epidemiology.
222. (1992). "Passive smoking and canine lung cancer risk". Am J Epidemiol.